Benzinga 对 $IOVA 的判断变化

频道资料 →频道引用的来源:AMD management、Apple management、Broadcom CEO Hock Tan、Counterpoint Research、Goldman Sachs、Intel management、JP Morgan、Jeff Kilberg (KKM Financial)、Jim Cramer / George Kurtz、Ken Langone、Lion、Microsoft management on the Q1 FY27 earnings call、Netflix management (Ted Sarandos, Greg Peters, Spence Newman)、Rothschild (rejected)、Swing Baron、Third party cited in the quote、Tim Melvin / Lawrence Chang、Timothy Horan (Oppenheimer)、Tom Saznoff、Uber management、Visa management共 1 条

Benzinga 自 2026-09-29 起在 1 个视频里谈过 $IOVA,最近一次(2026-09-29)为看涨。

2026-09-29看涨
《$150B Buyback! $NVDA Climbs as Futures Slip | PreMarket Playbook + T3 Live | September 29, 2026》
AI 摘要 · IOVA 技术动能强劲,且上调指引带来基本面催化剂,但因前期涨幅和期权流动性偏低而存在执行难度。

我第一个要说的是财报相关的 IOVA。现在这只股票绝对是眼下值得盯紧的一只。它是一只生物科技股。我一直在交易它,实际上从 8 涨到 10,然后你有没有过那种股票从你手里溜走的感觉——你交易着它,突然停了两天,它更高了,你就想,哦,我得再盯着它,然后它又更高了,你会觉得我该怎么重新进场?

IOVA 就是这种股票,现在它又来了。今天它上涨,是因为全年营收指引,归因于对该药物持续的需求。

The first one that I have is IOVA on earnings. Now, this stock is definitely one to keep an eye on right now. Uh it's a biotech stock. I've been trading it um actually up eight to 10 and then you ever have a stock that gets away from you where you're trading it and all of a sudden you stop for a couple days and it's higher and you're like oh I got to watch it again and then it's higher and you feel like how do I get back in?

IOVA is that kind of stock and here it goes again. Um up uh today it's up on uh fully year revenue guidance attributed to sustained demand for the drug.